Webinar: Biomarker Analysis Using the Simple Western Advances Pathogen Identification and Cancer Research
Biomarker discovery relies on the specific and accurate detection of protein targets that play key roles in regulatory response of pathogens as well as disease states in cancer cells and tissues. Immunodetection by Western blot analysis is a widely used technique to identify biomarkers involved in pathogen expression and cancer translational research. This technique has its challenges, namely unreliable data, semi-quantitative results, delayed time to results, reduced productivity and ultimately more costly research programs. ProteinSimple™ has introduced the Simple Western™, a novel capillary electrophoresis (CE) based immunodetection platform for protein separation by size or charge and characterization. It addresses the major challenges that researchers face with the traditional western blot. The Simple Western is a complete automated walk-away solution that is a gel-free, blot-free, and hands-free. In this webinar, participants will describe a range of applications utilizing the Simple Western technology. These applications address identification and characterization of emerging pathogens, and detection and quantitation of a key biomarker involved in acute lymphoblastic leukemia.
Philip Lorenzi, Ph.D., Surpervisor of Lab & Research, MD Anderson Cancer Center
David Hirschberg, Ph.D., Assistant Professor of Clinical Pathology, Columbia University
John Proctor, Ph.D., Director, Corporate Development, ProteinSimple